Most recently, Bright Peak Therapeutics raised $90.0M in its Later Stage VC (Series C) (Jun 2024).
- ·The complete investor list: 12 names
- ·Watch Bright Peak Therapeutics: the Monday email on marks, rounds and moves
Bright Peak Therapeutics round by round
2 roundsHow much has Bright Peak Therapeutics raised?
Bright Peak Therapeutics has raised $244 million across 2 recorded rounds since 2021. The largest was a $90 million Series C in Jun 2024.
Bright Peak Therapeutics has filed 2 Form Ds with the SEC since 2021, most recently in Jun 2024 ($90 million sold to 21 investors).
Bright Peak Therapeutics investors
12 investors are on record for Bright Peak Therapeutics, including Fidelity Management & Research Company, RA Capital Management, KB Investment and Alexandria Venture Investments. By type, the record holds 4 venture capital firms, 3 asset managers and 1 private equity firm. The Series C in Jun 2024 drew 9 investors.
12 investors have backed Bright Peak Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Bright Peak Therapeutics
- How much has Bright Peak Therapeutics raised?
- Bright Peak Therapeutics has raised $244.0M in total across 2 recorded funding rounds.
- When was Bright Peak Therapeutics's last funding round?
- Bright Peak Therapeutics's most recent recorded round was Later Stage VC (Series C) in Jun 2024, raising $90.0M.